Sorry, you need to enable JavaScript to visit this website.

Branded vs. Generic

  • Branded drugs are more expensive because they’re newer, generally groundbreaking, and often for conditions that are difficult to treat. However, after a certain period of time, these same innovative medicines become generic medicines.

  • The difference between our approach and that of many other companies is that when a medicine becomes a generic, we still assume responsibility. Rather than focus on just what’s in development, we continue to closely monitor the quality, safety, and reliability of our generic medicines.

Related Articles

Real People

'Science Has Kept Me Here': How Biomarker Research is Shaping the Future of Cancer Care

Debbie Pickworth shares her journey and experience after receiving a lung cancer diagnosis.

Programs & Initiatives

Bridging the Gap: Community-Based Organizations Seek Trust, Tools and Funding to Advance Public Health

Community-based organizations (CBOs) are the cornerstone of community health—yet across the country they face substantial uncertainty, according to a new national survey supported by the Pfizer Multicultural Health Equity Collective (The Collective).

Science & Innovation

Pursuing the Next Breakthrough in Cancer Cachexia

Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide. Currently, there are no FDA-approved treatments targeting its underlying cause.

How Drugs Are Made

The medicines available today have taken an average of 12 years to develop. With dedication, creativity, and science, we can significantly cut that time.

Clinical Trials

Learn more about the process of joining a clinical trial and find a trial near you.

Go to Pfizer Clinical Trials Site Details